0026-895X/03/6406-1485-1493$20.00
Mol Pharmacol 64:1485-1493, 2003
Hypoxia Inducible Factor-1
-Independent Suppression of Aryl Hydrocarbon Receptor-Regulated Genes by Nickel
Todd Davidson,
Konstantin Salnikow, and
Max Costa
Nelson Institute of Environmental Medicine, New York University School of Medicine, New York, New York
Aryl hydrocarbon receptor (AhR)-dependent enzymes are involved in the biotransformation of harmful xenobiotics into more easily excretable metabolites. Cross-talk between the AhR pathway and the hypoxia inducible factor-1
(HIF-1
) pathway has been demonstrated previously, although the mechanism remains unclear and quite controversial. Because nickel is known to mimic hypoxia, we investigated the effects of short-term nickel exposure on AhR-dependent gene expression. Gene-chip analysis identified several AhR-dependent genes that are suppressed by exposure to nickel. Using Northern blots, we then confirmed that nickel can down-regulate both the basal and benzo[a]pyrene-inducible expression of AhR-dependent genes in mouse and human cell lines. Using a HIF-1
knockout cell line and 3-[2-[4-(bis-(4-fluorophenyl) methylene]-1-piperidinyl)ethyl]-2,3-dihydro-2-thioxo-4(1H)quinazolinone (R59949), which blocks HIF-1
protein accumulation, we show HIF-1
-independent suppression of AhR-dependent genes by nickel. Desferrioxamine and hypoxia were also able to suppress the basal and inducible expression levels of AhR-regulated genes. Finally, dimethyloxalylglycine, an inhibitor of Fe(II)- and 2-oxoglutarate-dependent dioxygenases also inhibited AhR-dependent expression in a HIF-1
-independent manner. Our data suggest that an Fe(II)-, oxoglutarate-, and oxygen-dependent enzyme may directly or indirectly be involved in the regulation of AhR-dependent transcriptional activity by nickel and other hypoxia-mimicking agents.
Received May 5, 2003;
accepted August 28, 2003
Address correspondence to: Todd Davidson, 57 Old Forge Road, Tuxedo, NY 10987. E-mail: davidson{at}env.med.nyu.edu
This article has been cited by other articles:

|
 |

|
 |
 
Q. Li, Q. Ke, and M. Costa
Alterations of histone modifications by cobalt compounds
Carcinogenesis,
July 1, 2009;
30(7):
1243 - 1251.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Ke, Q. Li, T. P. Ellen, H. Sun, and M. Costa
Nickel compounds induce phosphorylation of histone H3 at serine 10 by activating JNK-MAPK pathway
Carcinogenesis,
June 1, 2008;
29(6):
1276 - 1281.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Chen and M. Costa
Effect of soluble nickel on cellular energy metabolism in a549 cells.
Experimental Biology and Medicine,
October 1, 2006;
231(9):
1474 - 1480.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Franco, S. Man, L. Chen, U. Emmenegger, Y. Shaked, A. M. Cheung, A. S. Brown, D. J. Hicklin, F. S. Foster, and R. S. Kerbel
Targeted Anti-Vascular Endothelial Growth Factor Receptor-2 Therapy Leads to Short-term and Long-term Impairment of Vascular Function and Increase in Tumor Hypoxia.
Cancer Res.,
April 1, 2006;
66(7):
3639 - 3648.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics